The CEIRS program continues and expands the Institute's animal influenza surveillance program internationally and domestically and focuses on several high priority areas in influenza research. The overall goal of this program is to provide the government with public health tools and strategies needed to control and lessen the impact of epidemic influenza and the increasing threat of pandemic influenza.
The SEAICRN was founded in 2005 in response to the global challenge posed by avian influenza to conduct research on influenza and other infectious diseases of importance to the region. It has evolved into a collaborative partnership of research institutions in Thailand, Vietnam, and Indonesia with NIAID, Oxford University Center for Tropical Medicine, the Wellcome Trust, and the World Health Organization.
NIAID initiated the Partnerships program to support research, development, and eventual commercialization of candidate products to address potential biological pathogen threats. The program has also been used to address high priority emerging diseases, such as SARS and avian influenza.